Loading...
•
Sep 30, 2023
Nu Skin Q3 2023 Earnings Report
Nu Skin's Q3 2023 results were softer than expected due to macro-economic challenges, particularly in Mainland China and the Americas, and a strong U.S. dollar, but stabilization and modest growth was seen in three Nu Skin reporting segments and accelerated growth in Rhyz businesses.
Key Takeaways
Nu Skin Enterprises reported Q3 2023 revenue of $498.8 million, a decrease compared to $537.8 million in the prior-year quarter. The company experienced a loss per share (EPS) of $(0.74), or $0.56 excluding an inventory write-off, compared to $(0.51) or $0.47 excluding restructuring and impairment charges in the prior year. The company is strategically re-evaluating several aspects of its Nu Skin business, including product portfolio, global processes and organization, and operational footprint and aggressively managing costs to help drive growth and profitability.
Revenue was $498.8 million, compared to $537.8 million in the prior-year quarter, impacted by foreign exchange rates by (1)%.
Loss per share (EPS) was $(0.74), or $0.56 excluding an inventory write-off, compared to $(0.51) or $0.47 excluding restructuring and impairment charges in the prior year.
The company is strategically re-evaluating several aspects of its Nu Skin business, including product portfolio, global processes and organization, and operational footprint.
A new mental wellness category will be introduced in 2024.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For Q4 2023, Nu Skin anticipates revenue between $440 to $480 million, with an approximate 3 percent negative foreign currency impact. Reported earnings per share are projected to be $(0.14) to $0.01, or $0.15 to $0.30 when excluding a fourth quarter restructuring charge.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...